Glutathione 200mg/mL MDV Recalled Due to Sterility Assurance Concerns
Red Mountain Compounding Pharmacy is recalling Glutathione 200mg/mL MDV (multiple-dose vials) because FDA inspection identified concerns that the product may lack proper sterility assurance. The product was distributed to patients in multiple states.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall involving a sterility assurance defect in a compounded injectable drug product. While no hospitalizations or illnesses are explicitly reported in the source text, the lack of sterility assurance in an injectable product intended for injection poses a significant risk of harm and justifies a Class II designation and Severe severity rating.
Plain-English summary
Red Mountain Compounding Pharmacy, operating as First Royal Care Co. LLC, is recalling Glutathione 200mg/mL MDV, a prescription injectable product, due to lack of assurance of sterility.
During an FDA inspection, sterility assurance concerns were raised regarding this compounded product. The recall affects all lots within their expiry period.
Approximately 494 patients who received prescriptions for this product are located in Arizona, California, Florida, Minnesota, Montana, Texas, and Utah. Consumers who have received this product should contact their healthcare provider or pharmacist for guidance.
This is a Class II recall issued by the FDA under recall number D-0038-2022.
The recalled product
- Product
- GLUTATHIONE 200MG/ML MDV, Rx only, Red Mountain Compounding Rx
- Manufacturer
- First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
- Category
- Drug — Compounded Injection
- Hazard
- sterility-assurance
- injectable-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- all lots within expiry
Distribution
Distributed in 7 states:
- AZ
- CA
- FL
- MN
- MT
- TX
- UT
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27